Syed Raza|S Raza, Syed I.Raza, SI. Raza

Syed Raza|S Raza, Syed I.Raza, SI. Raza

Amicus Therapeutics - Philadelphia / United States
Others
AD Scientific Index ID: 5691186
person_outline Syed Raza|S Raza, Syed I.Raza, SI. Raza's MOST POPULAR ARTICLES
1-) Prescribing in type 2 diabetes patients with and without cardiovascular disease history: a descriptive analysis in the UK CPRDRE Farmer, I Beard, SI Raza, ND Gollop, N Patel, A Tebboth, ...Clinical Therapeutics 43 (2), 320-335, 2021342021
2-) Long-term cost-effectiveness analyses of empagliflozin versus oral semaglutide, in addition to metformin, for the treatment of type 2 diabetes in the UKM Ramos, MH Cummings, A Ustyugova, SI Raza, SU de Silva, M LamotteDiabetes Therapy 11, 2041-2055, 2020252020
3-) Quality of Life with Late-Onset Pompe Disease: Qualitative Interviews and General Public Utility Estimation in the United KingdomKG Lena Hubig, Anna-Katrine Sussex, Alasdair MacCulloch, Derralynn Hughes ...Journal of Health Economics and Outcome Research 10 (1), 202342023
4-) Differential Appraisal of Functional Outcome Measures by Health Technology Assessment (HTA) Agencies When Reviewing Therapies for Rare Muscular, Skeletal and Neurodegenerative …S Raza, I Keyzor, S Shohet, M Zalewska, N Hummel, M BroughamValue in Health 25 (1), S175, 202232022
5-) Minimal clinically important differences in six-minute walking distance in late-onset Pompe diseaseKG Claeys, H Kushlaf, S Raza, N Hummel, S Shohet, I Keyzor, A Kopiec, ...Orphanet Journal of Rare Diseases 19 (1), 154, 202412024